BCAB vs J · $5.9M cap vs P/E 36, $14.40B cap
Bioatla Inc (BCAB) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
J does not have a complete income-statement cache yet.
BCAB currently screens at market cap $5.9M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the BCAB and J stock pages for the full models.
Not investment advice.